Female Hypogonadism
Female hypogonadism stems from disrupted ovarian‑pituitary signaling. Targeted biomarker testing clarifies where the axis falters and how severe it is. At Superpower, we measure LH, FSH, Estradiol, and Progesterone to map hypothalamic‑pituitary‑ovarian function and distinguish primary ovarian insufficiency from central (hypothalamic/pituitary) causes.
Female Infertility
Female infertility often reflects disrupted hypothalamic–pituitary–ovarian–thyroid signaling. Targeted biomarker testing clarifies ovulation status, ovarian reserve, and endocrine balance. At Superpower, we test FSH, LH, Estradiol, Progesterone, Prolactin, and TSH to map cycle dynamics, identify hormone dysregulation, and inform appropriate next diagnostic steps.
Homocystinuria
Homocystinuria signals trouble processing homocysteine, affecting methylation and sulfur amino acid pathways. Biomarker testing makes this visible. At Superpower, we test Homocysteine, Folate, and B12 to pinpoint remethylation or transsulfuration defects and gauge risks for blood clots, eye, bone, and nervous system complications.
Male Hypogonadism
Biomarker testing for male hypogonadism clarifies whether low energy, libido, or muscle loss reflect impaired testicular production (primary) or pituitary signaling (secondary). At Superpower, we measure Testosterone, Free T, Bioavailable T, LH, and FSH to map androgen availability and hypothalamic-pituitary-gonadal axis function.
Male Infertility
Male infertility often reflects disrupted hormonal signaling. Biomarker testing clarifies sperm-producing axis function and reveals treatable patterns. At Superpower, we measure Testosterone, Sex Hormone–Binding Globulin (SHBG), Free Androgen Index (FAI), Luteinizing Hormone (LH), and Follicle-Stimulating Hormone (FSH) to map hypothalamic–pituitary–gonadal dynamics and pinpoint where dysfunction arises.
Menopause
Menopause testing clarifies where you are in the reproductive transition by mapping ovarian‑pituitary signaling and hormone output. At Superpower, we measure FSH and LH (pituitary gonadotropins) alongside Estradiol and Progesterone (ovarian steroids) to interpret cycle shut‑down, follicular reserve, and symptom drivers with physiologic precision.
PCOS
PCOS is a hormonal–metabolic condition. Biomarker testing clarifies androgen excess, ovulation signaling, and insulin resistance. At Superpower, we test Testosterone, SHBG, FAI, LH, FSH, and Insulin to map the hypothalamic–pituitary–ovarian axis and androgen bioavailability, guiding accurate diagnosis and personalized monitoring.
